table of content
1 Introduction to Research & Analysis Reports
1.1 Peptide Receptor Radionuclide Therapy (PRRT) Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Peptide Receptor Radionuclide Therapy (PRRT) Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Peptide Receptor Radionuclide Therapy (PRRT) Overall Market Size
2.1 Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size: 2021 VS 2028
2.2 Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Peptide Receptor Radionuclide Therapy (PRRT) Players in Global Market
3.2 Top Global Peptide Receptor Radionuclide Therapy (PRRT) Companies Ranked by Revenue
3.3 Global Peptide Receptor Radionuclide Therapy (PRRT) Revenue by Companies
3.4 Top 3 and Top 5 Peptide Receptor Radionuclide Therapy (PRRT) Companies in Global Market, by Revenue in 2021
3.5 Global Companies Peptide Receptor Radionuclide Therapy (PRRT) Product Type
3.6 Tier 1, Tier 2 and Tier 3 Peptide Receptor Radionuclide Therapy (PRRT) Players in Global Market
3.6.1 List of Global Tier 1 Peptide Receptor Radionuclide Therapy (PRRT) Companies
3.6.2 List of Global Tier 2 and Tier 3 Peptide Receptor Radionuclide Therapy (PRRT) Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size Markets, 2021 & 2028
4.1.2 Gastroenteropancreatic Neuroendocrine Tumor
4.1.3 Foregut Neuroendocrine Tumor
4.1.4 Midgut Neuroendocrine Tumor
4.1.5 Hindgut Neuroendocrine Tumor
4.2 By Type - Global Peptide Receptor Radionuclide Therapy (PRRT) Revenue & Forecasts
4.2.1 By Type - Global Peptide Receptor Radionuclide Therapy (PRRT) Revenue, 2017-2022
4.2.2 By Type - Global Peptide Receptor Radionuclide Therapy (PRRT) Revenue, 2023-2028
4.2.3 By Type - Global Peptide Receptor Radionuclide Therapy (PRRT) Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size, 2021 & 2028
5.1.2 Hospital Pharmacies
5.1.3 Retail Pharmacies
5.1.4 Online Pharmacies
5.2 By Application - Global Peptide Receptor Radionuclide Therapy (PRRT) Revenue & Forecasts
5.2.1 By Application - Global Peptide Receptor Radionuclide Therapy (PRRT) Revenue, 2017-2022
5.2.2 By Application - Global Peptide Receptor Radionuclide Therapy (PRRT) Revenue, 2023-2028
5.2.3 By Application - Global Peptide Receptor Radionuclide Therapy (PRRT) Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size, 2021 & 2028
6.2 By Region - Global Peptide Receptor Radionuclide Therapy (PRRT) Revenue & Forecasts
6.2.1 By Region - Global Peptide Receptor Radionuclide Therapy (PRRT) Revenue, 2017-2022
6.2.2 By Region - Global Peptide Receptor Radionuclide Therapy (PRRT) Revenue, 2023-2028
6.2.3 By Region - Global Peptide Receptor Radionuclide Therapy (PRRT) Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Peptide Receptor Radionuclide Therapy (PRRT) Revenue, 2017-2028
6.3.2 US Peptide Receptor Radionuclide Therapy (PRRT) Market Size, 2017-2028
6.3.3 Canada Peptide Receptor Radionuclide Therapy (PRRT) Market Size, 2017-2028
6.3.4 Mexico Peptide Receptor Radionuclide Therapy (PRRT) Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Peptide Receptor Radionuclide Therapy (PRRT) Revenue, 2017-2028
6.4.2 Germany Peptide Receptor Radionuclide Therapy (PRRT) Market Size, 2017-2028
6.4.3 France Peptide Receptor Radionuclide Therapy (PRRT) Market Size, 2017-2028
6.4.4 U.K. Peptide Receptor Radionuclide Therapy (PRRT) Market Size, 2017-2028
6.4.5 Italy Peptide Receptor Radionuclide Therapy (PRRT) Market Size, 2017-2028
6.4.6 Russia Peptide Receptor Radionuclide Therapy (PRRT) Market Size, 2017-2028
6.4.7 Nordic Countries Peptide Receptor Radionuclide Therapy (PRRT) Market Size, 2017-2028
6.4.8 Benelux Peptide Receptor Radionuclide Therapy (PRRT) Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Peptide Receptor Radionuclide Therapy (PRRT) Revenue, 2017-2028
6.5.2 China Peptide Receptor Radionuclide Therapy (PRRT) Market Size, 2017-2028
6.5.3 Japan Peptide Receptor Radionuclide Therapy (PRRT) Market Size, 2017-2028
6.5.4 South Korea Peptide Receptor Radionuclide Therapy (PRRT) Market Size, 2017-2028
6.5.5 Southeast Asia Peptide Receptor Radionuclide Therapy (PRRT) Market Size, 2017-2028
6.5.6 India Peptide Receptor Radionuclide Therapy (PRRT) Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Peptide Receptor Radionuclide Therapy (PRRT) Revenue, 2017-2028
6.6.2 Brazil Peptide Receptor Radionuclide Therapy (PRRT) Market Size, 2017-2028
6.6.3 Argentina Peptide Receptor Radionuclide Therapy (PRRT) Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Peptide Receptor Radionuclide Therapy (PRRT) Revenue, 2017-2028
6.7.2 Turkey Peptide Receptor Radionuclide Therapy (PRRT) Market Size, 2017-2028
6.7.3 Israel Peptide Receptor Radionuclide Therapy (PRRT) Market Size, 2017-2028
6.7.4 Saudi Arabia Peptide Receptor Radionuclide Therapy (PRRT) Market Size, 2017-2028
6.7.5 UAE Peptide Receptor Radionuclide Therapy (PRRT) Market Size, 2017-2028
7 Players Profiles
7.1 Novartis
7.1.1 Novartis Corporate Summary
7.1.2 Novartis Business Overview
7.1.3 Novartis Peptide Receptor Radionuclide Therapy (PRRT) Major Product Offerings
7.1.4 Novartis Peptide Receptor Radionuclide Therapy (PRRT) Revenue in Global Market (2017-2022)
7.1.5 Novartis Key News
7.2 ITM Solucin
7.2.1 ITM Solucin Corporate Summary
7.2.2 ITM Solucin Business Overview
7.2.3 ITM Solucin Peptide Receptor Radionuclide Therapy (PRRT) Major Product Offerings
7.2.4 ITM Solucin Peptide Receptor Radionuclide Therapy (PRRT) Revenue in Global Market (2017-2022)
7.2.5 ITM Solucin Key News
7.3 National Institutes of Health
7.3.1 National Institutes of Health Corporate Summary
7.3.2 National Institutes of Health Business Overview
7.3.3 National Institutes of Health Peptide Receptor Radionuclide Therapy (PRRT) Major Product Offerings
7.3.4 National Institutes of Health Peptide Receptor Radionuclide Therapy (PRRT) Revenue in Global Market (2017-2022)
7.3.5 National Institutes of Health Key News
7.4 Australasian Gastro-Intestinal Trials Group
7.4.1 Australasian Gastro-Intestinal Trials Group Corporate Summary
7.4.2 Australasian Gastro-Intestinal Trials Group Business Overview
7.4.3 Australasian Gastro-Intestinal Trials Group Peptide Receptor Radionuclide Therapy (PRRT) Major Product Offerings
7.4.4 Australasian Gastro-Intestinal Trials Group Peptide Receptor Radionuclide Therapy (PRRT) Revenue in Global Market (2017-2022)
7.4.5 Australasian Gastro-Intestinal Trials Group Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
